参考文献/References:
[1] 叶 华,李 莉,钟贵芳,等.SICU严重脓毒症患者血降钙素原和乳酸清除率的临床分析[J].岭南现代临床外科,2015,15(6):707-710.
Ye H,Li L,Zhong GF,et al.Clinical analysis of serum procalcitonin and lactate clearance in patients with severe sepsis in SICU[J].Lingnan Modern Clinics in Surgery,2015,15(6):707-710.
[2] Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Crit Care Med,2013,41(2):580-637.
[3] Mandell LA,Wunderink RG,Anzueto A,et al.Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults[J].Clinical Infectious Diseases,2007,44(Suppl 2):S27-S72.
[4] 尹小燕,乔建瓯.甲状腺激素、降钙素原和C-反应蛋白对脓毒症患者病情及预后评估的价值[J].中华实验和临床感染病杂志(电子版),2016,10(2),162-165.
Yin XY,Qiao JO.Evaluating value of thyroid hormone and procalcitonin and C-reactive protein in patients with sepsis[J].Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition),2016,10(2),162-165.
[5] 石 岩,刘大为.降钙素原在全身性感染诊治中的研究进展[J].中华内科杂志,2011,50(5):444-446.
Shi Y,Liu DW.Research progress of procalcitonin in the diagnosis and treatment of systemic infection[J].Chinese Journal of Internal Medicine,2011,50(5):444-446.
[6] 刘婷婷,袁 喆.降钙素原的临床应用及研究进展[J].西部医学,2014,26(10):1408-1411.
Liu TT,Yuan Z.The clinical application and research progress of procalcitonin[J].Medical Journal of West China,2014,26(10):1408-1411.
[7] 秦海萍,庄建晴,曹维锷,等.降钙素原联合内毒素检测对老年脓毒症的临床意义[J].贵阳医学院学报,2016,41(4),483-486,490.
Qin HP,Zhuang JQ,Cao WE,et al.Clinical significance of procalcitonin and endotoxin detection in elderly sepsis[J].Journal of Guizhou MedicalCollege,2016,41(4),483-486,490.
[8] 黄志俭,雷利华,孙斐予,等.血浆内毒素在革兰阴性菌脓毒血症诊断及预后价值的研究[J].中华临床医师杂志(电子版),2016,10(4),217-218.
Huang ZJ,Lei LH,Sun FY,et al.The study on the value of plasma endotoxin in leather gram-negative bacteria sepsis diagnosis and prognosis[J].Chinese Journal of Clinicians(Electronic Edition),2016,10(4),217-218.
[9] 王 征,汤 辉,曹 涛,等.降钙素原和乳酸对急诊老年严重脓毒症和脓毒性休克患者预后的评估价值[J].现代中西医结合杂志,2016,25(19),2057-2059.
Wang Z,Tang H,Cao T,et al.Assess value of procalcitonin and lactate acid for the prognosis of emergency elderly patients with severe sepsis andsepsis shock[J].Modern Journal of Integrated Traditional Chinese and WesternMedicine,2016,25(19),2057-2059.
[10] Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:a severity of disease classfication system[J].Crit Care Med,1985,13(10):818-829.
[11] Bao B,Li ZG,Sun XL.Blood lactic acid level and APACHE Ⅱ score on prognosis of critically ill elderly patients[J].Chinese Journal of Epidemiology,2012,33(4):428-430.
相似文献/References:
[1]余 莉,郭 勇,车 頔,等.脓毒症患儿血RDW水平与PCIS评分及血乳酸的相关性研究[J].现代检验医学杂志,2019,34(03):86.[doi:10.3969/j.issn.1671-7414.2019.03.021]
YU Li,GUO Yong,CHE Di,et al.Correlation between RDW,PCISand Serum Lactic Acid in Children with Sepsis[J].Journal of Modern Laboratory Medicine,2019,34(02):86.[doi:10.3969/j.issn.1671-7414.2019.03.021]
[2]符征高,陈 钰,梁 勇,等.重症肺炎患者血清Fn,Copeptin及sTREM-1水平变化及临床意义[J].现代检验医学杂志,2021,36(04):111.[doi:10.3969/j.issn.1671-7414.2021.04.023]
FU Zheng-gao,CHEN Yu,LIANG Yong,et al.Changes and Clinical Significance of Serum Levels of Fn, Copeptin andsTREM-1 in Patients with Severe Pneumonia[J].Journal of Modern Laboratory Medicine,2021,36(02):111.[doi:10.3969/j.issn.1671-7414.2021.04.023]
[3]邱佳男,宋吉官,陈 龙,等.重症肺炎患者血清Presepsin,ICAM-1动态变化及其与预后的相关性研究[J].现代检验医学杂志,2021,36(06):166.[doi:10.3969/j.issn.1671-7414.2021.06.036]
QIU Jia-nan,SONG Ji-guan,CHEN Long,et al.Dynamic Changes of Serum Presepsin and ICAM-1 in Patients with Severe Pneumonia and Their Relationship with Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(02):166.[doi:10.3969/j.issn.1671-7414.2021.06.036]
[4]张 囝a,徐钰行b,骆宇琛c,等.重症肺炎脓毒症患者血清Sestrin2,TLR7 水平表达及对心力衰竭的预测价值分析[J].现代检验医学杂志,2024,39(03):131.[doi:10.3969/j.issn.1671-7414.2024.03.022]
ZHANG Jiana,XU Yuxingb,LUO Yuchenc,et al.Analysis of Serum Sestrin2 and TLR7 Level Expression in Patients with Severe Pneumonic Sepsis and Predictive Value for Heart Failure[J].Journal of Modern Laboratory Medicine,2024,39(02):131.[doi:10.3969/j.issn.1671-7414.2024.03.022]